ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$BHVN:NYSE · Biohaven Ltd

Sector: health

52-week range: 8.0318.24

Biohaven is a clinical-stage biopharmaceutical company developing therapies for neurological, neuropsychiatric, immunological, and rare diseases.

2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 58 — mean of 2 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater55New buy100,249$1,338,3240.0%
Paul Tudor Jones / Tudor61Trimmed -31%63,606$849,1400.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-03-09CHILDS JOHN Wdirector28,400$864,212Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.